How Elam was paid
$5.7M in total for 2026, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Other | Total |
|---|---|---|---|---|---|---|
| Nevan Charles ElamChief Executive Officer | $655,000 | $450,912 | $3,220,720 | $1,358,972 | $25,806 | $5,711,410 |
| Brian Roberts, M.D.Chief Medical Officer | $512,164 | $226,826 | $1,249,680 | $526,054 | $50,233 | $2,564,957 |
| Daron EvansChief Financial and Business Officer | $480,000 | $242,666 | $1,087,120 | $460,297 | $15,383 | $2,285,466 |
| Sunil KarnawatChief Commercial Officer | $415,625 | $237,301 | $488,870 | $1,456,235 | $25,878 | $2,623,909 |
What changed and why
- 5,711,410 was Elam’s 2026 total compensation, versus 2,851,109 in 2025; stock awards were the largest 2026 component.
- 50%2026 bonuses include estimated amounts for approximately 50% of target bonus amounts met for the 2026 calendar performance year.
- 60%Elam’s target bonus was up to 60% of annual base salary; Roberts’ was 40%, and Evans’ was 40%.
- October 2025 amendments entitled Elam and Roberts to tax gross-up payments for certain compensation subject to the Section 4999 excise tax.
Other Rezolute proxy statements
- 2025 proxy statement
Nevan Charles Elam paid $2.9M (+139% on the year).
Filed Oct 07, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.